News

McKnight's Long-Term Care News1d
RSV vaccine wanes in older adults over three seasons, trial shows
A single-dose of the respiratory syncytial virus (RSV) vaccine in older adults showed waning efficacy across three seasons of ...
MyChesCo on MSN3d
Expanded Recommendation for GSK’s AREXVY Vaccine Targets Adults at Higher Risk for Severe RSV
The Advisory Committee on Immunization Practices (ACIP) has voted to expand the recommended use of GSK’s AREXVY (Respiratory ...
Knowridge Science Report5d
Single-dose RSV vaccine protects older adults across three seasons, global study finds
A new global study led by GlaxoSmithKline has found that a single dose of the RSV vaccine Arexvy (RSVPreF3 OA) offers strong ...
pharmaphorum9d
There's good news for RSV jab firms at delayed ACIP meeting
The Advisory Committee on Immunisation Practices (ACIP) has voted to widen the recommendations on the use of RSV shots to ...
New Atlas11d
Over 60s get long-term protection against RSV from single shot
A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...
Fierce Pharma9d
RSV shots from GSK, Pfizer get potential boost from broadened ACIP guidance
A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...
MedPage Today on MSN10d
ACIP Endorses RSV Vaccine for At-Risk Adults 50 and Up
The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...
Can Moderna Keep the Beat Streak Alive This Earnings Season?
Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years
On Wednesday, the Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for the use of ...
Business Wire10d
AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices
About AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) AREXVY contains recombinant RSV glycoprotein F stabilized in the prefusion conformation (RSVPreF3). This antigen is combined with GSK ...